Pharma news

Reset all filters
Geography
Company
Refine search
BIO 2017: Panellists tackle patent concerns after Brexit
Pharma
Panellists discussed the potential impact of the UK’s decision to leave the EU on patents yesterday at the 2017 BIO International Convention.   22 June 2017
Pfizer and Takeda join BIO Ventures to tackle Africa cancer crisis
Africa
Pfizer and Takeda have joined together with non-profit BIO Ventures for Global Health and the African Organisation for Research and Training in Cancer to launch the African Access Initiative.   22 June 2017
Hospira sued for patent infringement over allergic injections
Americas
Florida-based company Belcher Pharmaceuticals has filed a complaint against Hospira for patent infringement.   21 June 2017
Americas
The perceived problem with 35 USC section 101 is a “fundamental question of national innovation policy”, claimed Kevin Rhodes, vice president and chief IP counsel at multinational conglomerate 3M.   21 June 2017
Americas
Pharmaceutical company Orexo has filed a complaint against Actavis Elizabeth and Teva Pharmaceuticals for infringing its patents covering Zubsolv.   20 June 2017
Pharma
The EU’s General Court will this month hear three competition cases involving generic companies, with the first—brought by Slovenian business Krka—being heard today.   20 June 2017
Americas
The US Court of Appeals for the Federal Circuit has affirmed a district court’s ruling in a dispute over diagnostic tests for cardiovascular diseases.   19 June 2017
Americas
Johnson & Johnson Innovation, the division that focuses on forming collaborations between entrepreneurs and J&J’s healthcare businesses, has announced a series of new collaborations.   16 June 2017
Americas
The Patent Trial and Appeal Board is not a “death squad” for drug patents, according to a study conducted by Fitzpatrick, Cella, Harper & Scinto.   15 June 2017
Americas
The US Court of Appeals for the Federal Circuit has affirmed a decision by the Patent Trial and Appeal Board (PTAB) which found that two patent applications by Purdue Pharma were unpatentable.   15 June 2017